Philips Begins Repair and Replacement of First Generation DreamStation Respiratory Care Devices

Kimberly Redmond  |

Image source: Recall Notification, Philips Respironics Sleep and Respiratory Care devices

Health technology giant Koninklijke Philips N.V (NYSE:  PHG

) will soon start repairing and replacing millions of respiratory devices in the US to address potential health risks posed by the machines. 

In June, the Dutch company recalled

Subscribe to get our Daily Fix delivered to your inbox 5 days a week

four million of its CPAP, BiPAP and ventilator devices, including its first generation DreamStation machines, after finding that the polyurethane (PE-PUR) sound abatement foam used in these products could degrade, become toxic and potentially cause cancer

In a press release on Wednesday, Philips said the US Food and Drug Administration (FDA) authorized the rework of the DreamStation devices, which involves replacing the sound abatement foam with a new material.

Eighty percent of the affected machines were sold in the US. The entire replacement effort will take about a year and cost about $601 million.

MedTech Dive noted that the recall was categorized as a “Class I” event by the FDA, the agency’s severest recall labeling. According to the FDA, more than 100 injuries and 1,200 complaints have been reported over the products. 

As a result, Philips is facing a growing number of class action lawsuits.   

In a statement on Wednesday, Frans van Houten, chief executive officer of Philips, said, “We fully recognize that the timeframe for remediation of the affected devices places patients in a difficult situation.”

“We are mobilized to deliver a solution to them as fast as possible. We have significantly increased our production, service and rework capacity, and further intensified our outreach to our customers and their patients. We urge patients with affected active devices to register these on the dedicated recall notification website.”


Source: Equities News

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content